News tagged with hepatitis c

No more free rides for 'piggy-backing' viruses

Scientists have determined the structure of the enzyme endomannosidase, significantly advancing our understanding of how a group of devastating human viruses including HIV and Hepatitis C hijack human enzymes to reproduce ...

Chemistry / Biochemistry

created Jan 04, 2012 | popularity 4 / 5 (1) | comments 0 | with audio podcast

Scavenger cells accomplices to viruses

Mucosal epithelia do not have any receptors on the outer membrane for the absorption of viruses like hepatitis C, herpes, the adenovirus or polio, and are thus well-protected against pathogenic germs. However, certain viruses, ...

Biology / Cell & Microbiology

created Jul 21, 2011 | popularity not rated yet | comments 0

US approves second new hepatitis C drug

The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month.

Medicine & Health / Medications

created May 23, 2011 | popularity not rated yet | comments 0

US regulators approve new hepatitis C drug

US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.

Medicine & Health / Medications

created May 14, 2011 | popularity not rated yet | comments 2

FDA panel endorses Vertex hepatitis C drug

(AP) -- Federal health experts say an experimental hepatitis C drug from Vertex Pharmaceuticals Inc. is a significant step forward in treating the virus, despite a high rate of rashes among patients taking the tablet.

Medicine & Health / Medications

created Apr 28, 2011 | popularity not rated yet | comments 0

US panel gives nod to Merck hepatitis C drug

A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.

Medicine & Health / Medications

created Apr 27, 2011 | popularity 5 / 5 (1) | comments 0

FDA says Vertex hepatitis drug is highly effective

(AP) -- Federal health officials say a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.

Medicine & Health / Medications

created Apr 26, 2011 | popularity not rated yet | comments 1

FDA says Merck drug successfully fights hepatitis

Federal health officials said Monday a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years. But the agency has questions ...

Medicine & Health / Medications

created Apr 25, 2011 | popularity not rated yet | comments 0

Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment

Berlin, Germany, Saturday 02 April 2011: Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant ...

Medicine & Health / Diseases, Conditions, Syndromes

created Apr 02, 2011 | popularity not rated yet | comments 0

Data suggest liver experts should take care when prescribing novel antiviral HCV drugs

Data presented at the International Liver Congress highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance ...

Medicine & Health / Diseases, Conditions, Syndromes

created Apr 02, 2011 | popularity not rated yet | comments 0

The future looks bright for HCV patients who have failed to respond to current treatments

Berlin, Germany, Friday 1st April 2011: Highly anticipated data from a number of clinical trials presented for the first time at the International Liver CongressTM confirmed that a range of new proteases inhibitors will help ...

Medicine & Health / Diseases, Conditions, Syndromes

created Apr 01, 2011 | popularity 5 / 5 (1) | comments 0

Game changer: Hepatitis C drug may revolutionize treatment

The drug boceprevir helps cure hard-to-treat hepatitis C, says Saint Louis University investigator Bruce R. Bacon, M.D., author of the March 31 New England Journal of Medicine article detailing the study's findings. The re ...

Medicine & Health / Diseases, Conditions, Syndromes

created Mar 30, 2011 | popularity 3 / 5 (2) | comments 0

Drug cocktail offers new hope for hepatitis C patients

A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital.

Medicine & Health / Diseases, Conditions, Syndromes

created Mar 30, 2011 | popularity 5 / 5 (1) | comments 0 | with audio podcast

The relationship between body mass index and age at hepatocellular carcinoma onset

A research team from Japan identified factors associated with the age at onset of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). The results showed that increased body mass index (BMI) is associated with ...

Medicine & Health / Diseases, Conditions, Syndromes

created Mar 15, 2011 | popularity 5 / 5 (1) | comments 0

Research suggests HIV-infected patients at higher risk for bone fractures

Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates ...

Medicine & Health / HIV & AIDS

created Mar 11, 2011 | popularity not rated yet | comments 0

Hepatitis C

Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but once established, chronic infection can progress to scarring of the liver (fibrosis), and advanced scarring (cirrhosis) which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure or other complications of cirrhosis, including liver cancer.

The hepatitis C virus (HCV) is spread by blood-to-blood contact. Most people have few, if any symptoms after the initial infection, yet the virus persists in the liver in about 85% of those infected. Persistent infection can be treated with medication, peginterferon and ribavirin being the standard-of-care therapy. Only 51% are cured overall. Those who develop cirrhosis or liver cancer may require a liver transplant, and the virus universally recurs after transplantation.

An estimated 270-300 million people worldwide are infected with hepatitis C. Hepatitis C is a strictly human disease. It cannot be contracted from or given to any animal. Chimpanzees can be infected with the virus in the laboratory, but do not develop the disease, which has made research more difficult. No vaccine against hepatitis C is available. The existence of hepatitis C (originally "non-A non-B hepatitis") was postulated in the 1970s and proved conclusively in 1989. It is one of five known hepatitis viruses: A, B, C, D, and E.

For more information about Hepatitis C, read the full article at Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.